Compare glaucoma shunt options to prevent cell loss
Part of Eyes & vision clinical trials.
This study compares a glaucoma drainage device approach to see which one better prevents loss of corneal cells after surgery. You may benefit by receiving close monitoring around the time of glaucoma surgery and helping doctors improve surgical choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- Your glaucoma is not well controlled with medicines/drops and you need surgery.
- Your planned operation includes a glaucoma drainage device (GDD), sometimes combined with cataract surgery (phacoemulsification).
- You have not had certain prior eye surgeries recently (shunts or trabeculectomy/MIGS) and you do not already have a GDD/Xen/Preserflo device.
- Your study eye has usable vision (not no light perception) and your other eye is not worse than 20/200.
- You do NOT have certain eye conditions such as past corneal transplant, severe corneal disease affecting cell health, uncontrolled uveitis, or conditions that raise eye vein pressure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three different tissues used to cover the tiny drainage device implanted during glaucoma surgery to prevent scarring. It aims to find which tissue works best to keep eye pressure low over time.
This study looks at whether two types of tiny drainage stents (PreserFlo and XEN) work safely to lower eye pressure in glaucoma. Some patients will also receive an amniotic membrane (a thin tissue that helps healing) during the surgery, and researchers will compare outcomes.
This study compares two types of drainage implants (Baerveldt and Paul) to see which one works better at lowering eye pressure in people with glaucoma. If your glaucoma is not controlled with eye drops or other treatments, this trial may help find a more effective option.
This trial tests a new suture method during glaucoma surgery with the Preserflo device to reduce the risk of low eye pressure after the operation. It may help people with certain types of glaucoma who need surgery because their eye pressure is not controlled by medications.
This study compares two types of eye surgery to lower pressure in the eye from glaucoma. It aims to find which surgery works better for people having their first glaucoma operation.
This trial studies outcomes after certain minimally invasive glaucoma surgeries, including the Preserflo microshunt. It may help improve how safely and effectively glaucoma surgery is done, and how patients are followed afterward.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.